Pulmonary Hypertension Association (PHA) Signs-On To IMedicor
Main Category: IT / Internet / E-mailAlso Included In: Primary Care / General Practice
Article Date: 22 Oct 2007 - 2:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Vemics, Inc.(PINK SHEETS:VMCI), a leading provider of hosted, real-time learning and productivity solutions, announces a partnership with the Pulmonary Hypertension Association (PHA) for the use of Vemics' iMedicorTM online portal - a unique patient information-sharing portal for physician collaboration. "It is wonderful to have the support of the Pulmonary Hypertension Association," said Tom Dorsett, President of Healthcare Solutions for Vemics. "iMedicor was developed for the very purpose of helping medical associations such as this to achieve its goals within the community and we are very proud to be a part of that."
"We hope that through iMedicor collaborative resources we will be able to continue to garner awareness of pulmonary hypertension and eventually a cure," said Rino Aldrighetti, President of PHA.
iMedicorTM is a HIPAA compliant, collaborative online portal designed for and by medical professionals to facilitate the secure exchange of medical records, educational content and ideas in real-time. The portal can also help doctors tap corresponding services from other professionals in the medical industry. Some of iMedicor's features include:
- An online referral and consultation community to create relationships that drive revenue
- An expansive multi-specialty video and text based CME / CEU catalog
- A voice recognition driven medical documentation system
- Medical association section that promotes regular interaction between associations and constituents. Healthcare groups section that allows healthcare professionals of like interests to identify one another and collaborate.
- Access to healthcare-specific blogs and forums.
- An events section that gives members and participating organizations the ability to publish up coming events to gain exposure and increase attendance.
- A practice improvement section that offers courses and information on better practice management
Only licensed medical professionals are permitted to access the free site at http://www.iMedicor.com.
About the Pulmonary Hypertension Association (PHA)
Founded in 1987, the Pulmonary Hypertension Association's (PHA) mission is to seek a cure for pulmonary hypertension and provide hope for the pulmonary hypertension community through support, education, advocacy, and awareness. Pulmonary Hypertension (PH) is a simplified name for a complex health problem - continuous high blood pressure in the lungs, resulting in an enlarged heart. PHA aids patients and their families in coping with this devastating disease; provides networking opportunities to end the "aloneness" of a rare illness; assists in locating doctors and medical facilities with expertise in treating pulmonary hypertension; forms support groups to allow patients to network and open contact with others; and publishes a newsletter, Pathlight, that builds a sense of community. http:// www.phassociation.org/
About Vemics, Inc.
Vemics, Inc. (PINK SHEETS:VMCI) is a leading provider of hosted, real-time learning and productivity solutions. Vemics LiveAccess™ solutions combine multipoint video/voice and data technologies with industry specific content, consulting expertise and deep customer support enabling organizations large and small to work, collaborate and learn face-to-face, online from almost anywhere with little or no capital investment. Vemics is based in New York with offices in Massachusetts, Pennsylvania, Moscow, St. Petersburg (Russia), Toronto (Canada) and Austin, Texas. http://www.vemics.com , http://www.imedicor.com
This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy ,integration of NuScribe's business into ours, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, as well as statements that include words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements. All forward-looking statements involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. Factors that may cause actual results to differ materially from those in the forward-looking statements include those set forth in our filings with http://www.pinksheets.com. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.
http://www.vemics.com
Visit our it / internet / e-mail section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/86236.php>
APA
http://www.medicalnewstoday.com/releases/86236.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



